BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32479952)

  • 1. Microbiome and host crosstalk: A new paradigm to cancer therapy.
    Singh A; Nayak N; Rathi P; Verma D; Sharma R; Chaudhary A; Agarwal A; Tripathi YB; Garg N
    Semin Cancer Biol; 2021 May; 70():71-84. PubMed ID: 32479952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics.
    Inamura K
    Semin Cancer Biol; 2021 May; 70():11-23. PubMed ID: 32580023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
    Chattopadhyay I; Nandi D; Nag A
    Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies for modulating the gut microbiome for cancer therapy.
    Cho YS; Han K; Xu J; Moon JJ
    Adv Drug Deliv Rev; 2024 Jul; 210():115332. PubMed ID: 38759702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease.
    Sharma VR; Singh M; Kumar V; Yadav M; Sehrawat N; Sharma DK; Sharma AK
    Semin Cancer Biol; 2021 May; 70():61-70. PubMed ID: 32693015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome in anti-cancer therapy.
    Bashiardes S; Tuganbaev T; Federici S; Elinav E
    Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome Modulates Response to Cancer Immunotherapy.
    Khan MAW; Ologun G; Arora R; McQuade JL; Wargo JA
    Dig Dis Sci; 2020 Mar; 65(3):885-896. PubMed ID: 32067144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in microbiome ecological balance providing a therapeutic window against cancer.
    Sehrawat N; Yadav M; Singh M; Kumar V; Sharma VR; Sharma AK
    Semin Cancer Biol; 2021 May; 70():24-36. PubMed ID: 32574811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible.
    Chadha J; Nandi D; Atri Y; Nag A
    Semin Cancer Biol; 2021 May; 70():112-127. PubMed ID: 32717337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and human cancer.
    Sepich-Poore GD; Zitvogel L; Straussman R; Hasty J; Wargo JA; Knight R
    Science; 2021 Mar; 371(6536):. PubMed ID: 33766858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and cancer risk reduction: The role of diet-microbiota interactions and microbial metabolites.
    Weir TL; Trikha SRJ; Thompson HJ
    Semin Cancer Biol; 2021 May; 70():53-60. PubMed ID: 32574813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the emerging role of the microbiome in cancer immunotherapy.
    Fessler J; Matson V; Gajewski TF
    J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.